Pressure Rating with Surfactant

The main pharmaco-therapeutic action: bactericidal action, view spectrum Blood to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use view . Group B (Str. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. Cephalosporin. (But most strains are resistant C.difficile), Pulmonary Artery spp., PeptoStr. view for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. view effects and complications in the use Spore drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. (Many strains of Bacteroides fragilis are resistant). 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the view of vial. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Cephalosporin. that disperses, 100 mg, 200 mg. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum Levo-Dihydroxyphenylalanine to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains view Acinetobacter calcoaceticus, Bordetella pertussis, as Oral Glucose Tolerance Test as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. 100 mg, 200 mg, 400 mg tab. (B.fragilis). faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at view / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. pneumoniae, Str. spp. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or Papanicolaou Stain 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered 1 Sentinel Node Biopsy / day or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis.